These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 23139417

  • 1. The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.
    Gang TB, Hammond DJ, Singh SK, Ferguson DA, Mishra VK, Agrawal A.
    J Biol Chem; 2012 Dec 14; 287(51):43116-25. PubMed ID: 23139417
    [Abstract] [Full Text] [Related]

  • 2. C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.
    Gang TB, Hanley GA, Agrawal A.
    Infect Immun; 2015 May 14; 83(5):1845-52. PubMed ID: 25690104
    [Abstract] [Full Text] [Related]

  • 3. A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide.
    Agrawal A, Simpson MJ, Black S, Carey MP, Samols D.
    J Immunol; 2002 Sep 15; 169(6):3217-22. PubMed ID: 12218140
    [Abstract] [Full Text] [Related]

  • 4. Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection.
    Singh SK, Ngwa DN, Agrawal A.
    Front Immunol; 2020 Sep 15; 11():1812. PubMed ID: 32903624
    [Abstract] [Full Text] [Related]

  • 5. Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide.
    Suresh MV, Singh SK, Ferguson DA, Agrawal A.
    J Immunol; 2007 Jan 15; 178(2):1158-1163. PubMed ID: 17202380
    [Abstract] [Full Text] [Related]

  • 6. Structure-Function Relationships of C-Reactive Protein in Bacterial Infection.
    Ngwa DN, Agrawal A.
    Front Immunol; 2019 Jan 15; 10():166. PubMed ID: 30863393
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Pneumococcal Infection by Using Engineered Human C-Reactive Protein in a Mouse Model.
    Ngwa DN, Singh SK, Gang TB, Agrawal A.
    Front Immunol; 2020 Jan 15; 11():586669. PubMed ID: 33117400
    [Abstract] [Full Text] [Related]

  • 8. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.
    Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ, Briles DE.
    J Immunol; 2012 Dec 01; 189(11):5327-35. PubMed ID: 23105137
    [Abstract] [Full Text] [Related]

  • 9. Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection.
    Suresh MV, Singh SK, Ferguson DA, Agrawal A.
    J Immunol; 2006 Apr 01; 176(7):4369-74. PubMed ID: 16547275
    [Abstract] [Full Text] [Related]

  • 10. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.
    Mold C, Rodic-Polic B, Du Clos TW.
    J Immunol; 2002 Jun 15; 168(12):6375-81. PubMed ID: 12055255
    [Abstract] [Full Text] [Related]

  • 11. Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein: role of Thr76 and Trp67.
    Agrawal A, Lee S, Carson M, Narayana SV, Greenhough TJ, Volanakis JE.
    J Immunol; 1997 Jan 01; 158(1):345-50. PubMed ID: 8977209
    [Abstract] [Full Text] [Related]

  • 12. Conformationally Altered C-Reactive Protein Capable of Binding to Atherogenic Lipoproteins Reduces Atherosclerosis.
    Pathak A, Singh SK, Thewke DP, Agrawal A.
    Front Immunol; 2020 Jan 01; 11():1780. PubMed ID: 32849641
    [Abstract] [Full Text] [Related]

  • 13. Purification of recombinant C-reactive protein mutants.
    Thirumalai A, Singh SK, Hammond DJ, Gang TB, Ngwa DN, Pathak A, Agrawal A.
    J Immunol Methods; 2017 Apr 01; 443():26-32. PubMed ID: 28167277
    [Abstract] [Full Text] [Related]

  • 14. The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.
    Agrawal A, Suresh MV, Singh SK, Ferguson DA.
    Endocr Metab Immune Disord Drug Targets; 2008 Dec 01; 8(4):231-7. PubMed ID: 19075776
    [Abstract] [Full Text] [Related]

  • 15. The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct.
    Black S, Agrawal A, Samols D.
    Mol Immunol; 2003 Jun 01; 39(16):1045-54. PubMed ID: 12749911
    [Abstract] [Full Text] [Related]

  • 16. C-reactive protein is protective against Streptococcus pneumoniae infection in mice.
    Mold C, Nakayama S, Holzer TJ, Gewurz H, Du Clos TW.
    J Exp Med; 1981 Nov 01; 154(5):1703-8. PubMed ID: 7299351
    [Abstract] [Full Text] [Related]

  • 17. C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.
    Ngwa DN, Singh SK, Agrawal A.
    Front Immunol; 2020 Nov 01; 11():620784. PubMed ID: 33552084
    [Abstract] [Full Text] [Related]

  • 18. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ, Edwards KM, Gewurz H, Mold C.
    J Immunol; 1984 Sep 01; 133(3):1424-30. PubMed ID: 6747291
    [Abstract] [Full Text] [Related]

  • 19. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.
    Szalai AJ, Briles DE, Volanakis JE.
    Infect Immun; 1996 Nov 01; 64(11):4850-3. PubMed ID: 8890251
    [Abstract] [Full Text] [Related]

  • 20. A novel phosphocholine antigen protects both normal and X-linked immune deficient mice against Streptococcus pneumoniae. Comparison of the 6-O-phosphocholine hydroxyhexanoate-conjugate with other phosphocholine-containing vaccines.
    Fischer RT, Longo DL, Kenny JJ.
    J Immunol; 1995 Apr 01; 154(7):3373-82. PubMed ID: 7897220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.